Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of CYP3A4 rs2242480 With Sufentanil Plasma Concentration and PCA Consumption

NCT02070614 is registered in ClinicalTrials.gov with Xianwei Zhang as lead sponsor.

NCT NCT02070614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02070614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of CYP3A4 rs2242480 With Sufentanil Plasma Concentration and PCA Consumption
Lead sponsor
Xianwei Zhang
Phase
Observational
Overall status
Completed
Start date
December 31, 2013
Completion date
May 31, 2014
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

individuality, surgery